Xingqi Dong

Xingqi Dong


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2017 in Viruses
Verified
Journal Article
Open access
PDF file
ZMZhijiang Miao
Zhijiang Miao
LGLi Gao
Li Gao
YSYindi Song
Yindi Song
MYMing Yang
Ming Yang
MZMi Zhang
Mi Zhang
XXXueshan Xia
Xueshan Xia
Human Pegivirus-1 (HPgV-1) may have a beneficial impact on disease progression in human immunodeficiency virus-1 (HIV-1) infection. However, analysis of the genotypic diversity of HPgV-1 and its relevance to the progression of HIV-1 disease remains limited. A total of 1062 HIV-1-infected individuals were recruited in all sixteen prefectures of Yunnan province, China. The reverse transcription nested polymerase chain reaction (RT-nPCR), phylogenetic analyses, and clinical data analyses were used to detect HPgV-1 infection, determine genotype, and analyze HPgV-1 genotype impact on HIV-1 disease progression. The overall positive rate of HPgV-1 RNA was 23.4% (248/1062), and the frequency of HPgV-1 infection in injecting drug users (IDUs) (28.5%, 131/460) was significantly higher than in heterosexuals (19.4%, 117/602). Multiple genotypes were identified in 212 subjects with successful sequencing for the E2 gene, including genotype 7 (55.7%), genotype 3 (34.9%), genotype 4 (4.7%), genotype 2 (3.3%), and an unclassified group (1.4%). Moreover, genotype 7 predominated in IDUs, whereas genotype 3 was the most common in heterosexuals. Our results revealed that HPgV-1 genotype 7 groups exhibited significantly lower HIV-1 viral load and higher CD4+ cell counts. This finding suggests that HPgV-1 genotype 7 may be associated with a better progression of HIV-1 disease.

1 September 2019 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
CZChunyue Zhang
Chunyue Zhang
YFYue Feng
Yue Feng
LGLi Gao
Li Gao
MZMi Zhang
Mi Zhang
JMJing Miao
Jing Miao
XXXueshan Xia
Xueshan Xia

2 September 2019 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
AZA-Mei Zhang
A-Mei Zhang
MYMing Yang
Ming Yang
LGLi Gao
Li Gao
MZMi Zhang
Mi Zhang
LJLingshuai Jiao
Lingshuai Jiao
XXXueshan Xia
Xueshan Xia
Hepatitis C virus (HCV) infection was frequent in human immunodeficiency virus (HIV) patients in Yunnan province. We studied the epidemic characteristics of HCV in HIV/HCV co-infected patients. Serum from 894 HIV-1 patients was collected, together with basic information and biochemical features. All samples were infected with HIV through injecting drug users (IDUs) and sexual transmission (ST). The NS5B gene was amplified and sequenced to affirm HCV genotype. In total, 202 HIV patients were co-infected with HCV, and most (81.19%) of co-infected patients were IDUs. Genotype 3b was predominant (37.62%) in these samples, and its frequency was similar in patients with IDU and ST. The frequencies of genotypes 1a, 1b, 3a, 6a, 6n, 2a and 6u were 3.96%, 16.34%, 23.76%, 6.93%, 10.40%, 0.50% and 0.50%, respectively. However, genotype 3a showed significantly different frequency in HCV patients with IDU and ST (P = 0.019). When HCV patients were divided into subgroups, the haemoglobin (HGB) level was significantly higher in patients with genotype 3a than in patients with 3b (P = 0.033), 6a (P = 0.006) and 6n (P = 0.007), respectively. Although no difference existed among HCV subgroups, HIV-viral load was identified to be positively correlated with the HGB level and CD4+ cells when dividing HCV/HIV co-infected persons into male and female groups. In conclusion, genotype 3b was the predominant HCV genotype in Yunnan HIV/HCV co-infected persons. The HGB level was higher in patients with genotype 3a than others. HIV-viral load was positively correlated with the HGB level and CD4+ cells in the male or female HCV-infected group.

1 December 2018 in Journal of Infection
Verified
Journal Article
Closed access
YFYue Feng
Yue Feng
CZChunyue Zhang
Chunyue Zhang
MZMi Zhang
Mi Zhang
LGLi Gao
Li Gao
JMJing Miao
Jing Miao
XXXueshan Xia
Xueshan Xia

24 March 2022 in Journal of Infection
Verified
Journal Article
Closed access
MXMeng Xiao
Meng Xiao
YFYue Feng
Yue Feng
LGLi Gao
Li Gao
CYCuixian Yang
Cuixian Yang
JLJiafa Liu
Jiafa Liu
XXXueshan Xia
Xueshan Xia

24 September 2022 in Virologica Sinica
Verified
Journal Article
Open access
XFXiao-Li Feng
Xiao-Li Feng
DYDandan Yu
Dandan Yu
MZMi Zhang
Mi Zhang
XLXiaohong Li
Xiaohong Li
QZQing-Cui Zou
Qing-Cui Zou
MLMing Hua Li
Ming Hua Li
The continuously arising of SARS-CoV-2 variants has been posting a great threat to public health safety globally, from B.1.17 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta) to B.1.1.529 (Omicron). The emerging or re-emerging of the SARS-CoV-2 variants of concern is calling for the constant monitoring of their epidemics, pathogenicity and immune escape. In this study, we aimed to characterize replication and pathogenicity of the Alpha and Delta variant strains isolated from patients infected in Laos. The amino acid mutations within the spike fragment of the isolates were determined via sequencing. The more efficient replication of the Alpha and Delta isolates was documented than the prototyped SARS-CoV-2 in Calu-3 and Caco-2 ​cells, while such features were not observed in Huh-7, Vero E6 and HPA-3 ​cells. We utilized both animal models of human ACE2 (hACE2) transgenic mice and hamsters to evaluate the pathogenesis of the isolates. The Alpha and Delta can replicate well in multiple organs and cause moderate to severe lung pathology in these animals. In conclusion, the spike protein of the isolated Alpha and Delta variant strains was characterized, and the replication and pathogenicity of the strains in the cells and animal models were also evaluated.